Related Experiment Video
Updated: Jan 25, 2026
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Recent advancements in cancer vaccine developments: novel approaches
Balisa Mosisa Ejeta1, Malay K Das1, Sanjoy Das1
1Department of Pharmaceutical Sciences, Dibrugarh University, Assam, India.
Abstract:
Harnessing the immune system, vaccines function as both prophylactic shields and precision-guided therapeutic agents, offering a promising strategy of a dual-armament approach in the fight against cancer. Previous landmark advances include identification of tumor-associated antigens (TAAs) and the development of dendritic cell vaccines and viral-vector platforms that laid the groundwork for modern personalized approaches. Cancer vaccines represent a transformative approach in oncology, harnessing the immune system to prevent, treat, or eliminate malignancies. Recent advances focus on improving the efficacy of immune responses, enhancing immunogenicity, and overcoming tumor immune evasion. Unlike conventional chemotherapy, which lacks durable immunity and often leads to relapse, cancer vaccines can induce long-term immune memory, reducing recurrence risks. They also mitigate drug resistance through adaptive immune targeting and synergize effectively with immune checkpoint inhibitors. With favorable safety profiles, reduced toxicity, and long-term cost benefits, cancer vaccines offer a precision-based alternative to traditional therapies. However, challenges such as tumor heterogeneity, immunosuppression, and high costs remain. Future research should optimize vaccine design, refine delivery systems, and explore combination strategies to maximize clinical outcomes. This review explores cutting-edge cancer vaccine platforms, including therapeutic (dendritic cell, peptide, mRNA, and viral vector-based vaccines), preventive (HPV and HBV vaccines), and combination immunotherapy strategies, while addressing, limitations and future directions in the field.
Insights
Cancer vaccines harness the immune system for prevention and treatment, offering long-term memory and reduced toxicity compared to chemotherapy. Ongoing research aims to optimize designs and overcome challenges like tumor heterogeneity for improved outcomes.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines utilize the immune system as a dual-approach strategy for cancer prevention and therapy.
- Advances in tumor-associated antigens (TAAs) and vaccine platforms (dendritic cell, viral-vector) have enabled personalized cancer treatments.
- Cancer vaccines offer potential for long-term immune memory, reduced relapse rates, and mitigation of drug resistance, unlike conventional chemotherapy.
Purpose of the Study:
- To review cutting-edge cancer vaccine platforms, including therapeutic, preventive, and combination immunotherapy strategies.
- To discuss the advantages of cancer vaccines, such as enhanced immunogenicity, reduced toxicity, and cost-effectiveness.
- To address current limitations and future research directions in cancer vaccine development.
Main Methods:
- Review of therapeutic cancer vaccine platforms: dendritic cell, peptide, mRNA, and viral vector-based vaccines.
- Examination of preventive vaccines (e.g., HPV, HBV) and their role in cancer reduction.
- Analysis of combination immunotherapy strategies involving cancer vaccines.
Main Results:
- Cancer vaccines can induce durable immune memory, reduce recurrence, and overcome drug resistance.
- Therapeutic vaccines demonstrate potential for personalized treatment, improved safety profiles, and reduced toxicity.
- Preventive vaccines like HPV and HBV have shown success in reducing cancer incidence.
Conclusions:
- Cancer vaccines represent a transformative, precision-based approach in oncology with significant advantages over traditional therapies.
- Overcoming challenges like tumor heterogeneity and immunosuppression is crucial for maximizing vaccine efficacy.
- Future research should focus on optimizing vaccine design, delivery systems, and combination strategies to improve clinical outcomes.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
00:56Extraction: Advanced Methods
02:22Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
01:20Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
01:08Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...